First US Eliquis Generics Face Six-Year Wait

Mylan And Micro Labs Have Settled With BMS Over Apixaban

Skydiver_2026
BMS expects its Eliquis exclusivity to fall in 2026 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation